1627 related articles for article (PubMed ID: 8605733)
21. nm23--relationship to the metastatic potential of breast carcinoma cell lines, primary human xenografts, and lymph node negative breast carcinoma patients.
Russell RL; Geisinger KR; Mehta RR; White WL; Shelton B; Kute TE
Cancer; 1997 Mar; 79(6):1158-65. PubMed ID: 9070493
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.
Campo E; Miquel R; Jares P; Bosch F; Juan M; Leone A; Vives J; Cardesa A; Yague J
Cancer; 1994 Jun; 73(12):2913-21. PubMed ID: 8199988
[TBL] [Abstract][Full Text] [Related]
23. Metastatic phenotype in hybrid cells derived from B16 melanoma.
Ito M; Izuhara M; Shimizu K; Sekiguchi M
Cancer Lett; 1994 Apr; 78(1-3):33-9. PubMed ID: 8180966
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N
Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374
[TBL] [Abstract][Full Text] [Related]
25. Expression of metastasis suppressor gene product, nm23 protein, is not inversely correlated with the tumour progression in human malignant melanomas.
Saitoh K; Takahashi H; Yamamoto M; Kishi H; Parsons PG
Histopathology; 1996 Dec; 29(6):497-505. PubMed ID: 8971556
[TBL] [Abstract][Full Text] [Related]
26. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.
Ma D; Luyten GP; Luider TM; Jager MJ; Niederkorn JY
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2293-301. PubMed ID: 8843913
[TBL] [Abstract][Full Text] [Related]
27. Metastasis associated MTS1 and NM23 genes affect tubulin polymerisation in B16 melanomas: a possible mechanism of their regulation of metastatic behaviour of tumours.
Lakshmi MS; Parker C; Sherbet GV
Anticancer Res; 1993; 13(2):299-303. PubMed ID: 8390799
[TBL] [Abstract][Full Text] [Related]
28. Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).
Miele ME; De La Rosa A; Lee JH; Hicks DJ; Dennis JU; Steeg PS; Welch DR
Clin Exp Metastasis; 1997 May; 15(3):259-65. PubMed ID: 9174127
[TBL] [Abstract][Full Text] [Related]
29. Increasing metastatic potential is associated with induced chromosome 14 translocations in a previously nonmetastatic murine melanoma cell line.
Nemeth MA; Wilson MR; Fidler IJ; Pathak S
Cancer Genet Cytogenet; 1997 Oct; 98(2):119-25. PubMed ID: 9332476
[TBL] [Abstract][Full Text] [Related]
30. [Expression and anti-metastatic potential of nm 23/NDP kinase in human head and neck cancer cells].
Miyazaki H
Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):189-95. PubMed ID: 9711037
[TBL] [Abstract][Full Text] [Related]
31. Somatic allelic deletion of nm23 in human cancer.
Leone A; McBride OW; Weston A; Wang MG; Anglard P; Cropp CS; Goepel JR; Lidereau R; Callahan R; Linehan WM
Cancer Res; 1991 May; 51(9):2490-3. PubMed ID: 2015608
[TBL] [Abstract][Full Text] [Related]
32. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene.
Lee JH; Miele ME; Hicks DJ; Phillips KK; Trent JM; Weissman BE; Welch DR
J Natl Cancer Inst; 1996 Dec; 88(23):1731-7. PubMed ID: 8944003
[TBL] [Abstract][Full Text] [Related]
33. Differentiation and metastasis in melanoma.
Rusciano D
Crit Rev Oncog; 2000; 11(2):147-63. PubMed ID: 11005510
[TBL] [Abstract][Full Text] [Related]
34. Establishment and characterization of an oral melanoma cell line (ME).
Chang KW; Lin SC; Chao SY; Kwan PC; Chiu CP; Wong YK
Oral Oncol; 2001 Apr; 37(3):301-7. PubMed ID: 11287286
[TBL] [Abstract][Full Text] [Related]
35. The loss of NM23 protein in malignant melanoma predicts lymphatic spread without affecting survival.
Döme B; Somlai B; Tímár J
Anticancer Res; 2000; 20(5C):3971-4. PubMed ID: 11268486
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of the promoter for the human metastasis suppressor gene nm23-H1.
de la Rosa A; Mikhak B; Steeg PS
Arch Med Res; 1996; 27(3):395-401. PubMed ID: 8854401
[TBL] [Abstract][Full Text] [Related]
37. The NM23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with BglII.
Varesco L; Caligo MA; Simi P; Black DM; Nardini V; Casarino L; Rocchi M; Ferrara G; Solomon E; Bevilacqua G
Genes Chromosomes Cancer; 1992 Jan; 4(1):84-8. PubMed ID: 1377015
[TBL] [Abstract][Full Text] [Related]
38. Gene structure, promoter activity, and chromosomal location of the DR-nm23 gene, a related member of the nm23 gene family.
Martinez R; Venturelli D; Perrotti D; Veronese ML; Kastury K; Druck T; Huebner K; Calabretta B
Cancer Res; 1997 Mar; 57(6):1180-7. PubMed ID: 9067290
[TBL] [Abstract][Full Text] [Related]
39. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line.
Welch DR; Bisi JE; Miller BE; Conaway D; Seftor EA; Yohem KH; Gilmore LB; Seftor RE; Nakajima M; Hendrix MJ
Int J Cancer; 1991 Jan; 47(2):227-37. PubMed ID: 1671030
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of N-acetylglucosaminyltransferase V by tumorigenesis- or metastasis-suppressor gene and its relation to metastatic potential of human hepatocarcinoma cells.
Guo HB; Liu F; Zhao JH; Chen HL
J Cell Biochem; 2000 Sep; 79(3):370-85. PubMed ID: 10972975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
